Asthma remission in patients with eosinophilic granulomatosis with polyangiitis (EGPA) following treatment with benralizumab or mepolizumab

被引：0

作者：

Bourdin, Arnaud ^{[1
]}

Wechsler, Michael E. ^{[2
]}

Jackson, David J. ^{[3
]}

Siddiqui, Salman ^{[4
]}

Baudy, Peter ^{[5
]}

Menzies-Gow, Andrew ^{[6
]}

Necander, Sofia ^{[7
]}

Shavit, Anat ^{[6
]}

Walton, Claire ^{[8
]}

机构：

[1] Univ Montpellier, Dept Resp Dis, CHU Montpellier, INSERM, Montpellier, France

[2] Natl Jewish Hlth, Dept Med, Denver, CO USA

[3] Kings Coll London, Guys Severe Asthma Ctr, London, England

[4] Imperial Coll London, Hammersmith & Royal Brompton Hosp, Natl Heart & Lung Inst, London, England

[5] AstraZeneca, Resp & Immunol US Med, Wilmington, DE USA

[6] AstraZeneca, BioPharmaceutials Med, Cambridge, England

[7] AstraZeneca, Late Stage Resp & Immunol, BioPharmaceut R&D, AstraZeneca Med, Gothenburg, Sweden

[8] AstraZeneca, Late Stage Resp & Immunol, BioPharmaceut R&D, Cambridge, England

来源：

关键词：

D O I：

10.1183/13993003.congress-2024.PA5364

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

引用

页数：2